Product NewsClinical Diagnostics
Reducing LOS and Improving MI Diagnosis Using Guidance-Acceptable cTn Assays
15 Oct 2015![Reducing LOS and Improving MI Diagnosis Using Guidance-Acceptable cTn Assays Reducing LOS and Improving MI Diagnosis Using Guidance-Acceptable cTn Assays](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/b0997aede58e6785f0c7269ab0e2fba6eccb668e-805x450.jpg?w=3840&q=75&fit=clip&auto=format)
Katherine Soreng, PhD, Director of Clinical and Scientific Marketing at Siemens Healthcare Diagnostics, discusses the use of troponin as a marker of myocardial damage and its appropriate use in MI diagnosis. Learn how you can reduce length of patient stay and improve the earlier diagnosis of MI with guideline-acceptable assays.